148 related articles for article (PubMed ID: 17962369)
1. Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia.
Farre L; Bittencourt AL; Silva-Santos G; Almeida A; Silva AC; Decanine D; Soares GM; Alcantara LC; Van Dooren S; Galvão-Castro B; Vandamme AM; Van Weyenbergh J
J Leukoc Biol; 2008 Jan; 83(1):220-2. PubMed ID: 17962369
[TBL] [Abstract][Full Text] [Related]
2. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
[TBL] [Abstract][Full Text] [Related]
4. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
Lee YH; Kim YR; Ji JD; Sohn J; Song GG
J Rheumatol; 2001 Sep; 28(9):2008-11. PubMed ID: 11550967
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers.
Tsukasaki K; Miller CW; Kubota T; Takeuchi S; Fujimoto T; Ikeda S; Tomonaga M; Koeffler HP
Cancer Res; 2001 May; 61(9):3770-4. PubMed ID: 11325850
[TBL] [Abstract][Full Text] [Related]
6. Fas promoter region gene polymorphism is associated with an increased risk for myocardial infarction.
Hanasaki H; Takemura Y; Fukuo K; Ohishi M; Onishi M; Yasuda O; Katsuya T; Awata N; Kato N; Ogihara T; Rakugi H
Hypertens Res; 2009 Apr; 32(4):261-4. PubMed ID: 19262492
[TBL] [Abstract][Full Text] [Related]
7. A polymorphism in FAS gene promoter associated with increased risk of nasopharyngeal carcinoma and correlated with anti-nuclear autoantibodies induction.
Bel Hadj Jrad B; Mahfouth W; Bouaouina N; Gabbouj S; Ahmed SB; Ltaïef M; Jalbout M; Chouchane L
Cancer Lett; 2006 Feb; 233(1):21-7. PubMed ID: 16473667
[TBL] [Abstract][Full Text] [Related]
8. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
[TBL] [Abstract][Full Text] [Related]
9. FAS-670A/G single nucleotide polymorphism may be associated with human T lymphotropic virus-1 infection and clinical evolution to TSP/HAM.
Vallinoto AC; Santana BB; dos Santos EL; Santo RR; Hermes RB; Sousa RC; Cayres-Vallinoto I; Machado LF; Ishak MO; Ishak R
Virus Res; 2012 Jan; 163(1):178-82. PubMed ID: 21971214
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
Zhang Z; Wang LE; Sturgis EM; El-Naggar AK; Hong WK; Amos CI; Spitz MR; Wei Q
Clin Cancer Res; 2006 Sep; 12(18):5596-602. PubMed ID: 17000697
[TBL] [Abstract][Full Text] [Related]
11. Fas-1377 A/G polymorphism in lung cancer.
Gormus U; Ergen A; Yaylim-Eraltan I; Yilmaz H; Turna A; Bozkurt N; Isbir T
In Vivo; 2007; 21(4):663-6. PubMed ID: 17708363
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen-class II-negative long-term cultured human T-cell leukemia virus type-I-infected T-cell lines with progressed cytological properties significantly induce superantigen-dependent normal T-cell proliferation.
Nagasaki M; Zhang J; Morikawa S; Harada T; Nabika T; Tanaka Y
Pathol Int; 2005 May; 55(5):264-72. PubMed ID: 15871724
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Fas gene promoter polymorphism in cervical cancer patients.
Dybikowska A; Sliwinski W; Emerich J; Podhajska AJ
Int J Mol Med; 2004 Sep; 14(3):475-8. PubMed ID: 15289903
[TBL] [Abstract][Full Text] [Related]
14. The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome.
Miceli-Richard C; Gestermann N; Ittah M; Comets E; Loiseau P; Puechal X; Hachulla E; Gottenberg JE; Lebon P; Becquemont L; Mariette X
Arthritis Rheum; 2009 Jul; 60(7):1991-7. PubMed ID: 19565491
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between juvenile idiopathic arthritis and fas gene polymorphism.
Donn R; Zeggini E; Shelley E; Ollier W; Thomson W;
J Rheumatol; 2002 Jan; 29(1):166-8. PubMed ID: 11824955
[TBL] [Abstract][Full Text] [Related]
16. GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore.
Hong Y; Eu KW; Seow-Choen F; Fook-Chong S; Cheah PY
Eur J Cancer; 2005 May; 41(7):1037-44. PubMed ID: 15862753
[TBL] [Abstract][Full Text] [Related]
17. FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.
Zhang Z; Xue H; Gong W; Wang M; Yuan L; Han S; Zhang Z
Carcinogenesis; 2009 Mar; 30(3):487-93. PubMed ID: 19168581
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of Fas and Fas ligand in preterm premature rupture of membranes in singleton pregnancies.
Fuks A; Parton LA; Polavarapu S; Netta D; Strassberg S; Godi I; Hsu CD
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1132-6. PubMed ID: 16157125
[TBL] [Abstract][Full Text] [Related]
19. A polymorphism in FAS gene promoter correlated with circulating soluble FAS levels.
Mahfoudh W; Bel Hadj Jrad B; Romdhane A; Chouchane L
Int J Immunogenet; 2007 Jun; 34(3):209-12. PubMed ID: 17504511
[TBL] [Abstract][Full Text] [Related]
20. Association of FAS -1377 G>A and FAS -670 A>G functional polymorphisms of FAS gene of cell death pathway with recurrent early pregnancy loss risk.
Nair RR; Khanna A; Singh K
J Reprod Immunol; 2012 Mar; 93(2):114-8. PubMed ID: 22386066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
